Pages

Welcome, 77 artists, 40 different points of Attica welcomes you by singing Erotokritos an epic romance written at 1713 by Vitsentzos Kornaros

Tuesday, July 28, 2015

STOCKS FALL FOR 5TH STRAIGHT DAY: Here's what you need to know (SPY, DJI, IXIC, GLD, GLX, USO, WTI, OIL, VDE, TEVA, MYL, AGN, 000001)

Stocks fell on Monday for a fifth straight session. The Dow dropped to its lowest level since early February, and the S&P 500 saw its third five-day streak of losses this year. First, the scoreboard: Dow: 17,434.51, -134.02, (-0.76%) S&P 500: 2,067.23, -12.42, (-0.60%) Nasdaq: 5,041.76, -46.87, (-0.92%) And now, the top stories on Monday: Chinese stocks had their worst day in eight years. The Shanghai Composite fell 8.48% on Monday, its worst one-day percentage drop since February 2007. Every sector closed lower, and the index is down 10% from Thursday's close. Brent crude is in a bear market. In futures trading, the international benchmark of oil prices tumbled more than 2% to close at $53.47 per barrel. A bear market is roughly defined as a 20% drop from highs. On Thursday, West Texas Intermediate crude oil fell into a bear market, and reached a fresh four-month low near $47 per barrel on Monday. In economic data, durable goods orders climbed more than expected in June, boosted by a jump in transportation orders. Headline orders rose 3.4% (3.2% expected, -1.8% prior), and excluding the volatile transportation and defense components, orders rose 0.8% (0.4% expected, 0.4% prior). The data for May was revised lower. "On net, despite June strength, the long-awaited stabilization in capex orders still looks like a hope rather than a reality," wrote UBS' Maury Harris in a note to clients after the data. The Dallas Fed manufacturing index came in at -4.6, below the estimate for -7. Activity in Texas moderated, and a few survey respondents said there's a seasonal lull. Heavy rainfall in May, and weaker energy prices also took their toll on business activity, according to respondents. Israel-based Teva Pharmaceuticals is buying Allergan's generic drug unit for $40.5 billion It's the latest in the mega-deal frenzy that's happening in the industry. Teva rallied more than 15%, and Allergan shares gained 6%. Teva abandoned its bid for Mylan, whose shares tanked 15%. DON'T MISS: We're about to get a much better idea of just how well the US economy is doing »SEE ALSO: Yes, there really was a secret plan to hack the Greek state and bring back the drachma DON'T MISS: Your complete preview of this week's big economic events Join the conversation about this story » NOW WATCH: This animated map shows how religion spread across the world


READ THE ORIGINAL POST AT uk.businessinsider.com